Periocular routes for retinal drug delivery
- 1 November 2004
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 1 (1), 99-114
- https://doi.org/10.1517/17425247.1.1.99
Abstract
Despite numerous scientific efforts, delivery of therapeutic amounts of a drug to the retina remains a challenge. This challenge is compounded if chronic therapy is desired. The inability or inefficiency of topical and systemic routes for retinal delivery of existing drugs is now widely accepted. Although the intravitreal route offers high local concentrations in the vitreous and, hence, retina, these advantages are offset by side effects, such as cataracts, endophthalmitis and retinal detachment, following repeated intravitreal injections, or intravitreal placement of sustained-release implants. As discussed in this review, periocular routes, including subconjunctival, sub-tenon, retrobulbar, peribulbar and posterior juxtascleral routes, potentially offer a more promising alternative for enhanced drug delivery to the retina compared with topical and systemic routes. Periocular routes exploit the permeability of sclera for retinal drug delivery, and they are particularly useful for administering sustained-release systems of potent drugs. This review discusses the various periocular routes with respect to their anatomical location, pharmacokinetics, safety and mechanisms of drug delivery. In the coming years, several innovations in absorption enhancement, drug delivery systems and drug administration devices are anticipated for improving retinal drug delivery via periocular routes.Keywords
This publication has 43 references indexed in Scilit:
- Sub-Tenon's administration of local anaesthetic: a review of the techniqueBritish Journal of Anaesthesia, 2003
- Retinal venous oxygen saturation and cardiac output during controlled hemorrhage and resuscitationJournal of Applied Physiology, 2003
- Drug Delivery to the Posterior Segment of the Eye: Some Insights on the Penetration Pathways after Subconjunctival InjectionJournal of Ocular Pharmacology and Therapeutics, 2001
- New developments in sustained release drug delivery for the treatment of intraocular diseaseBritish Journal of Ophthalmology, 1999
- Clinically Important Ocular Reactions to Systemic Drug TherapyDrug Safety, 1993
- Pharmacokinetics of Newer Cephalosporins After Subconjunctival and Intravitreal Injection in RabbitsAmerican Journal of Ophthalmology, 1993
- Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal InjectionAmerican Journal of Ophthalmology, 1992
- Aminoglycoside Toxicity—A Survey of Retinal SpecialistsAmerican Journal of Ophthalmology, 1991
- Ocular Toxicity from Systemic Drug therapyMedical Toxicology, 1986
- The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitisDocumenta Ophthalmologica, 1975